Related Experiment Videos
[Transurethral microwave thermotherapy for benign prostatic hyperplasia]
K Kawamura1, A Kikuyama, M Moriyama
1Department of Urology, Kanazawa Medical University.
Hinyokika Kiyo. Acta Urologica Japonica
|November 1, 1993
Summary
Transurethral microwave thermotherapy (TUMT) improved symptoms for benign prostatic hyperplasia patients. While flow rates increased, results were less significant than transurethral resection of the prostate (TUR-P).
Area of Science:
- Urology
- Minimally Invasive Therapies
Context:
- Benign prostatic hyperplasia (BPH) causes bladder outlet obstruction.
- Transurethral microwave thermotherapy (TUMT) is a treatment option for BPH.
Purpose:
- To evaluate the clinical efficacy and side effects of transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia (BPH).
Summary:
- Ten patients with BPH underwent TUMT using the Prostatron device, heating the prostate to 45.5°C for 55 minutes.
- Most patients experienced symptomatic improvement and increased flow rates, with minimal side effects like transient hematuria.
- TUMT showed lower maximum flow rates and less improvement in residual urine compared to transurethral resection of the prostate (TUR-P).
Impact:
- TUMT offers a minimally invasive option for BPH symptom relief.
- The study highlights the comparative effectiveness of TUMT versus TUR-P.
- Further research may optimize TUMT protocols for better outcomes.